EMA
safety_alert
· 2021-06-11
Vaxzevria: EMA advises against use in people with history of capillary leak syndrome
Summary
EMA advisory recommends against using Vaxzevria in individuals with a history of capillary leak syndrome due to potential risk of recurrence or worsening.
Upgrade for the full analysis, importance score, and drug timeline.